Brief: Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress For ALS-4 Targeting Staphylococcus Aureus, And Positive Pre-INDProgress For SACT-1 Targeting Neuroblastoma

Aptorum

24/05/2021 13:21

May 24 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP ANNOUNCES POSITIVE INTERIM PHASE I CLINICAL
TRIAL
PROGRESS FOR ALS-4 TARGETING STAPHYLOCOCCUS AUREUS AND POSITIVE
PRE-IND PROGRESS FOR SACT-1 TARGETING NEUROBLASTOMA
    * APTORUM GROUP LTD - SACT-1 ON TRACK TO OPEN AN IND TO
COMMENCE
CLINICAL STUDIES IN Q3 2021
    * APTORUM GROUP LTD - REMAINING ALS-4 PHASE I STUDY WILL
CONTINUE
TO PROGRESS

Source text for Eikon:  ID:nBw48KtSla 
Further company coverage:  APM.O 

 ((Reuters.Briefs@thomsonreuters.com;))